Literature DB >> 3816707

High-dose phenytoin in the treatment of refractory epilepsy.

J E Cobos.   

Abstract

Refractory, long-standing, high-frequency epilepsy was successfully managed with high-dose phenytoin treatment. Side effects were observed in only three patients and were easily corrected. Most of the patients had partial seizures, but many also had a myoclonic component. Emphasis was placed on monotherapy whenever possible. Results, interpretation of serum levels, and toxic reactions to phenytoin are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3816707     DOI: 10.1111/j.1528-1157.1987.tb03635.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Is there a role for therapeutic drug monitoring of new anticonvulsants?

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  2000-03       Impact factor: 6.447

3.  Epileptic patients refractory to drug therapy.

Authors:  L Paris; M Giardina; R Pacifici; S Pichini; P Zuccaro; G Sideri
Journal:  Ital J Neurol Sci       Date:  1991-10

4.  Factors affecting the free plasma fraction of phenytoin in patients with epilepsy.

Authors:  M C Jiménez; J A Durán; J A Abad In
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.